A phase Ib trial of ZED 1227 for the treatment of celiac disease
Latest Information Update: 14 Dec 2017
At a glance
- Drugs ZED 1227 (Primary)
- Indications Coeliac disease
- Focus Adverse reactions
- 02 May 2017 Status changed from recruiting to completed, according to a Zedira GmbH media release.
- 19 Jul 2016 New trial record